Autologous platelet-rich plasma for treating surgical wounds

To determine the efficacy and safety of autologous PRP compared to placebo, standard treatment, and  alternative treatments such as plasma poor in platelets, laser (common in plastic surgery) or biomaterials (e.g. acellular xenogeneic dermal matrix or Keratinocyte suspension; Appendix 1), for surgical wounds.

This is a protocol.